Accueil

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on

Study Description: 
There are few therapies suitable for the treatment of psoriasis on the face and skin folds. As these areas are sensitive, irritation and other adverse reactions are more common than elsewhere on the body. The purpose of the study is to compare the efficacy and safety of once daily treatment for up to 8 weeks of an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g with tacalcitol 4 mcg/g ointment and the ointment vehicle alone in patients with psoriasis vulgaris on the face and on the intertriginous areas.
Maladies et affections de la peau: 
Psoriasis
Study Start Date: 
février 2008
Estimated completion date: 
mars 2009
Study Location(s): 
Waterloo
Province: 
Ontario
Healthy Volunteers: 
Yes
Study Director/Investigator: 
Colin Fleming, MD Ninewells Hospital & Medical School
Pour nous joindre: 
Kirsten L Nørrelund, MSc Pharm +4544945888 kirsten.noerrelund@leo-pharma.com
Rikke L Fischer +4544945888 rikke.fischer@leo-pharma.com

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Christine Jackson, Executive Director
phone: 613-422-4265
fax: 613-422- 4267
 

pageTracker._trackPageview();